Calendar

pharmadog

Week of Feb 9, 2026

Feb 11, 2026approval201d agoCAMCEVI KIT (LEUPROLIDE MESYLATE) — FDA approvalForesee Pharmaceuticals Co Ltd

Sponsor: ACCORD. Form: EMULSION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Feb 11, 2026approval201d agoNARCAN (NALOXONE HYDROCHLORIDE) — FDA approvalEmergent Devices Inc

Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL

full page →fda approvals ↗

Feb 11, 2026approval201d agoAUBAGIO (TERIFLUNOMIDE) — FDA approvalteriflunomide

Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

full page →teriflunomide →fda approvals ↗

Feb 11, 2026approval201d agoGLATIRAMER ACETATE — FDA approvalGLATIRAMER ACETATE

Sponsor: HYBIO. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →GLATIRAMER ACETATE →fda approvals ↗

Feb 11, 2026approval201d agoPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalPAXLOVID (COPACKAGED)

Sponsor: PFIZER. Form: TABLET. Route: ORAL

full page →PAXLOVID (COPACKAGED) →fda approvals ↗

Feb 11, 2026approval201d agoPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalPAXLOVID (COPACKAGED)

Sponsor: PFIZER. Form: TABLET. Route: ORAL

full page →PAXLOVID (COPACKAGED) →fda approvals ↗

Feb 11, 2026approval201d agoBRIMONIDINE TARTRATE — FDA approvalBausch & Lomb Corp

Sponsor: DR REDDYS LABS SA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗

Feb 11, 2026grant201d agoUNIVERSITY OF TEXAS SAN ANTONIO — Development of small molecule inhibitors of RBM46 as novel male contraceptives

HD grant. $743,116. PI: Christopher Bennett Geyer

full page →nih reporter ↗

Feb 11, 2026grant201d agoCLEVELAND CLINIC LERNER COM-CWRU — Pathogenesis of Permanent Neurological Disability in Multiple Sclerosis

NS grant. $544,568. PI: BRUCE D TRAPP

full page →nih reporter ↗

Feb 11, 2026grant201d agoUNIVERSITY OF IOWA — Identifying novel regulators of Tfh cell differentiation that can be targeted...University of Iowa

AI grant. $427,625. PI: Ryan Zander

full page →nih reporter ↗

Feb 11, 2026grant201d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — A parabrachial hub for the prioritization of pain and other survival behaviors

NS grant. $620,504. PI: John Nicholas Betley

full page →nih reporter ↗

Feb 11, 2026grant201d agoUNIVERSITY OF PENNSYLVANIA — Single-nucleus gene expression and chromatin accessibility profiling of sleep...University of Pennsylvania

NS grant. $243,750. PI: Xiaofeng Guo

full page →nih reporter ↗

Feb 11, 2026grant201d agoUNIVERSITY OF DELAWARE — Evaluating Force Deficits During Bimanual Coordination in Parkinson's Disease...Metallomix Inc

NS grant. $80,000. PI: Roxana Gabriela Burciu

full page →nih reporter ↗

Feb 11, 2026grant201d agoBAYLOR COLLEGE OF MEDICINE — STATE-DEPENDENT MODULATION OF CEREBELLAR FUNCTIONBaylor College of Medicine

NS grant. $508,533. PI: JAVIER F MEDINA

full page →nih reporter ↗

Feb 11, 2026grant201d agoUNIVERSITY OF PENNSYLVANIA — The impact of a personalized video-based stroke educational platform onpatien...University of Pennsylvania

NS grant. $644,345. PI: Christopher G. Favilla

full page →nih reporter ↗

Feb 11, 2026grant201d agoINDIANA UNIVERSITY INDIANAPOLIS — World Parkinson Congress 2026 Support

NS grant. $25,000. PI: Maria de Lourdes Gamez Tansey

full page →nih reporter ↗

Feb 12, 2026approval200d agoCLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

full page →CLEOCIN →fda approvals ↗

Feb 12, 2026approval200d agoCLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approvalclindamycin hydrochloride

Sponsor: PFIZER. Form: CAPSULE. Route: ORAL

full page →clindamycin hydrochloride →fda approvals ↗

Feb 12, 2026approval200d agoCLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

full page →CLEOCIN →fda approvals ↗

Feb 12, 2026approval200d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

full page →tramadol hydrochloride ER →fda approvals ↗

Feb 12, 2026approval200d agoENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) — FDA approvalENJUVIA

Sponsor: ASPEN. Form: TABLET. Route: ORAL

full page →ENJUVIA →fda approvals ↗

Feb 12, 2026approval200d agoFLUOROMETHOLONE — FDA approvalDifGen Pharmaceuticals LLC

Sponsor: DIFGEN PHARMS. Form: SUSPENSION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗

Feb 12, 2026approval200d agoLEQVIO (INCLISIRAN SODIUM) — FDA approvalinclisiran

Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS

full page →inclisiran →fda approvals ↗

Feb 12, 2026approval200d agoLEQVIO (INCLISIRAN SODIUM) — FDA approvalinclisiran

Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS

full page →inclisiran →fda approvals ↗

Feb 12, 2026approval200d agoPROMETRIUM (PROGESTERONE) — FDA approvalIBSA Institut Biochimique SA

Sponsor: ACERTIS PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 12, 2026approval200d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

Sponsor: ALKEM. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 12, 2026approval200d agoADQUEY (DIFAMILAST) — FDA approvaldifamilast

Sponsor: ACROTECH BIOPHARMA. Form: OINTMENT. Route: TOPICAL

full page →difamilast →fda approvals ↗

Feb 12, 2026approval200d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →GLATIRAMER ACETATE →fda approvals ↗

Feb 12, 2026approval200d agoENZEEVU (AFLIBERCEPT-ABZV) — FDA approvalaflibercept biosimilar

Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION

full page →aflibercept biosimilar →fda approvals ↗

Feb 12, 2026approval200d agoBIJUVA (ESTRADIOL) — FDA approval(estradiol + progesterone)

Sponsor: MAYNE PHARMA. Form: CAPSULE. Route: ORAL

full page →(estradiol + progesterone) →fda approvals ↗

Feb 12, 2026approval200d agoESTRING (ESTRADIOL) — FDA approvalestradiol ER

Sponsor: PFIZER. Form: INSERT, EXTENDED RELEASE. Route: VAGINAL

full page →estradiol ER →fda approvals ↗

Feb 12, 2026approval200d agoPEPCID AC (FAMOTIDINE) — FDA approvalKenvue Inc.

Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 12, 2026approval200d agoAMMONIUM LACTATE — FDA approvalAMMONIUM LACTATE

Sponsor: ZYDUS LIFESCIENCES. Form: CREAM. Route: TOPICAL

full page →AMMONIUM LACTATE →fda approvals ↗

Feb 12, 2026approval200d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →GLATIRAMER ACETATE →fda approvals ↗

Feb 12, 2026approval200d agoDIVIGEL (ESTRADIOL) — FDA approvalVertical Pharmaceuticals LLC

Sponsor: VERTICAL PHARMS. Form: GEL. Route: TRANSDERMAL

full page →fda approvals ↗

Feb 12, 2026approval200d agoCENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approvalCENESTIN

Sponsor: ASPEN. Form: TABLET. Route: ORAL

full page →CENESTIN →fda approvals ↗

Feb 12, 2026approval200d agoDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval(daratumumab + hyaluronidase (human recombinant))

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →(daratumumab + hyaluronidase (human recombinant)) →fda approvals ↗

Feb 12, 2026approval200d agoCELECOXIB — FDA approvalScilex Holding Co

Sponsor: QINGDAO BAHEAL PHARM. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 12, 2026grant200d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Capacity Building for the Diagnosis and Treatment of Neuromyelitis Optica usi...Northwestern University

TW grant. $372,306. PI: Farrah Jasmine Mateen

full page →nih reporter ↗

Feb 12, 2026grant200d agoUNIVERSITY OF NEW MEXICO HEALTH SCIS CTR — Investigating the Role of CircRNAs in Pain and Nocieptive Sensitization

GM grant. $191,972. PI: June Bryan de la Pena

full page →nih reporter ↗

Feb 12, 2026grant200d agoUNIVERSITY OF MINNESOTA — Differentiation and characteristics of Helios+ CD8+ T cellsUniversity of Minnesota

AI grant. $407,326. PI: STEPHEN C JAMESON

full page →nih reporter ↗

Feb 12, 2026grant200d agoRUTGERS THE STATE UNIV OF NJ CAMDEN — In vivo platforms for exploring co-evolution of ligands, receptors, and their...

GM grant. $423,734. PI: Nir Yakoby

full page →nih reporter ↗

Feb 13, 2026approval199d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

Sponsor: ZYDUS LIFESCIENCES. Form: GEL. Route: TOPICAL

full page →METRONIDAZOLE →fda approvals ↗

Feb 13, 2026approval199d agoAVOPEF (ETOPOSIDE) — FDA approvaletoposide

Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAVENOUS

full page →etoposide →fda approvals ↗

Feb 13, 2026approval199d agoCEFAZOLIN SODIUM — FDA approvalSamson Medical Technologies LLC

Sponsor: HQ SPCLT PHARMA. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 13, 2026approval199d agoWAKIX (PITOLISANT HYDROCHLORIDE) — FDA approvalpitolisant hydrochloride

Sponsor: HARMONY. Form: TABLET. Route: ORAL

full page →pitolisant hydrochloride →fda approvals ↗

Feb 13, 2026approval199d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

Sponsor: UNICHEM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 13, 2026approval199d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

Sponsor: UNICHEM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 13, 2026approval199d agoAMMONIA N 13 (AMMONIA N-13) — FDA approval

Sponsor: WA UNIV SCH MED. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 13, 2026approval199d agoRYBREVANT FASPRO (AMIVANTAMAB AND HYALURONIDASE-LPUJ) — FDA approval(amivantamab + hyaluronidase (human recombinant))

Sponsor: JANSSEN BIOTECH. Form: VIAL. Route: SINGLE-USE

full page →(amivantamab + hyaluronidase (human recombinant)) →fda approvals ↗

← prev

page 428 of 475

Week of Feb 9, 2026